Then, expanding on the immunotherapy strategy, CXCR4-targeted immunostimulatory nanoparticles incorporating inflammatory proteins such as Gasdermin D (GSDMD) or Mixed Lineage Kinase Domain-Like protein (MLKL) were developed to induce tumor-selective pyroptotic cell death and subsequent activation of the immune system. This evidence concerns the gene MLKL and neoplasm.